Price $51.68 |
Market Cap
1.12B
|
Sector Health Care |
Div. Growth
14.10%
|
|
P/E
54.5
|
P/B
4.16
|
P/S
6.91
|
Dividend %
1.10%
|
|
P/CF
212.3
|
P/FCF
100.7
|
Op. Cash Flow
25.4K
|
FCF
0.5
|
|
Op. Margin
16.60%
|
Net Margin
12.80%
|
ROE
7.90%
|
ROI
7.40%
|
|
ROA
6.90%
|
EPS Growth
-26.30%
|
Current Ratio
6.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Emmaus Life Sciences Inc (EMMA) | $0.33 | - | - | 19.2M | Strong Buy |
| IM Cannabis Corp (IMCC) | $0.70 | - | - | 13.9M | Strong Buy |
| Milestone Scientific Inc (MLSS) | $0.89 | - | - | 55.1M | Strong Buy |
| BioSig Technologies Inc (BSGM) | $1.15 | - | - | 55.9M | Strong Buy |
| Chembio Diagnostics Inc (CEMI) | $0.43 | - | - | 16.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
